MAPT and Alzheimer disease: Previous studies have consistently indicated protective clinical and pathological roles of APOE ε2, such as delayed emergence of AD,8 decreased Aβ and tau deposition in the brain,35, 60 increased gray matter volume,61 and slower cognitive decline.62